NCT04254913View on ClinicalTrials.gov

Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 24, 2020

Primary Completion Date

April 16, 2020

Study Completion Date

April 22, 2020

Conditions
Japanese Patients With ALS
Interventions
DRUG

MT-1186

Suspension

Trial Locations (1)

Unknown

Investigational site, Chiba

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY